Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06687694Recruiting

Immune Mechanisms of Antipsychotic Treatment Response

Role: collaborator

NCT07008742Recruiting

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer

Role: collaborator

NCT06763471Not ApplicableNot Yet Recruiting

Measuring Single Neuron Activity in the Brain

Role: collaborator

NCT04815850Completed

Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

Role: collaborator

NCT05432739Recruiting

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Role: collaborator

NCT04750356Unknown

SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)

Role: collaborator

NCT03226886Unknown

TRACERx Renal CAPTURE Sub-study

Role: collaborator

All 7 trials loaded